Literature DB >> 7499384

Possible role for serine/threonine phosphorylation in the regulation of the heteroprotein complex between the hsp90 stress protein and the pp60v-src tyrosine kinase.

E G Mimnaugh1, P J Worland, L Whitesell, L M Neckers.   

Abstract

The abundant, cytoplasmic 90-kDa heat-shock protein associates transiently with the Rous sarcoma virus oncogenic protein tyrosine kinase, pp60v-src, directs its cellular trafficking and negatively regulates its kinase activity. Here we report that the serine/threonine phosphatase inhibitor, okadaic acid, destabilized the heat-shock protein 90-pp60v-src chaperone complex in v-src-transfected cells. Concomitant with complex destabilization by okadaic acid, phosphoserine was doubled and phosphothreonine was increased 20-fold in the heat-shock protein 90. Although phosphorylation of the total pool of immunoprecipitable pp60v-src was unchanged, okadaic acid slightly increased phosphoserine and phosphothreonine levels specifically in pp60v-src bound to heat-shock protein 90. The low level of tyrosine phosphorylation in the pp60v-src complexed with heat-shock protein 90 was further decreased by okadaic acid. Interestingly, okadaic acid-stabilized hyperphosphorylation of the heat-shock protein 90-pp60v-src complex lowered the level of pp60v-src in cell membranes, the functional location for pp60v-src. We suggest that serine/threonine phosphorylation of heat-shock protein 90 and/or pp60v-src functions as a regulatory molecular trigger to release pp60v-src from the chaperone complex at the inner surface of cell membranes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499384     DOI: 10.1074/jbc.270.48.28654

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

Authors:  H J Ochel; K Eichhorn; G Gademann
Journal:  Cell Stress Chaperones       Date:  2001-04       Impact factor: 3.667

2.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

Review 3.  Post-translational modifications of Hsp90 and translating the chaperone code.

Authors:  Sarah J Backe; Rebecca A Sager; Mark R Woodford; Alan M Makedon; Mehdi Mollapour
Journal:  J Biol Chem       Date:  2020-06-11       Impact factor: 5.157

Review 4.  Toxoplasma gondii Hsp90: potential roles in essential cellular processes of the parasite.

Authors:  Sergio O Angel; Maria J Figueras; Maria L Alomar; Pablo C Echeverria; Bin Deng
Journal:  Parasitology       Date:  2014-02-21       Impact factor: 3.234

5.  An acetylation site in the middle domain of Hsp90 regulates chaperone function.

Authors:  Bradley T Scroggins; Kenneth Robzyk; Dongxia Wang; Monica G Marcu; Shinji Tsutsumi; Kristin Beebe; Robert J Cotter; Sara Felts; David Toft; Larry Karnitz; Neal Rosen; Len Neckers
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

6.  Detecting Posttranslational Modifications of Hsp90.

Authors:  Rebecca A Sager; Mark R Woodford; Len Neckers; Mehdi Mollapour
Journal:  Methods Mol Biol       Date:  2018

7.  LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung.

Authors:  Nektarios Barabutis; Vaishali Handa; Christiana Dimitropoulou; Ruslan Rafikov; Connie Snead; Sanjiv Kumar; Atul Joshi; Gagan Thangjam; David Fulton; Stephen M Black; Vijay Patel; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-12       Impact factor: 5.464

8.  Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation.

Authors:  Tushar B Deb; Christine M Coticchia; Robert Barndt; Hong Zuo; Robert B Dickson; Michael D Johnson
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-18       Impact factor: 4.249

9.  Phase I study of BIIB028, a selective heat shock protein 90 inhibitor, in patients with refractory metastatic or locally advanced solid tumors.

Authors:  David Hong; Rabih Said; Gerald Falchook; Aung Naing; Stacy Moulder; Apostolia-Maria Tsimberidou; Gerald Galluppi; Naveen Dakappagari; Chris Storgard; Razelle Kurzrock; Lee S Rosen
Journal:  Clin Cancer Res       Date:  2013-07-19       Impact factor: 12.531

10.  Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase.

Authors:  Martine Duval; Fabrice Le Boeuf; Jacques Huot; Jean-Philippe Gratton
Journal:  Mol Biol Cell       Date:  2007-09-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.